Study of mouth and throat cancer patterns in Fanconi anemia
Part of Blood & lymphatic, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how squamous cell carcinoma (a type of cancer) naturally develops over time in people with Fanconi anemia. It may help doctors better recognize warning signs and plan care in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) are age 12 or older, or age 8–11 with ongoing concerning symptoms
- You have Fanconi anemia (FA), and it must be verifiable based on your referral information
- You can provide consent (or a parent/guardian can) and understand what the study involves
- If you live outside the U.S., you can travel to the USA on your own
- You can have had cancer before and still be eligible
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study observes and talks with adults with Fanconi anemia about their feelings during cancer screening visits. It aims to learn how to better support people with FA through screening anxiety.
This study looks at why people with inherited bone marrow failure syndromes (rare genetic conditions affecting blood cell production) have higher cancer risk. Researchers want to understand the genetic and medical factors that increase cancer likelihood, which could help doctors monitor and protect affected patients and their families.
This study screens people who may have an inherited risk for certain cancers due to their personal or family medical history or known gene changes. By completing a survey, you can help researchers find the right study for you and learn more about your cancer risk.
This study uses MRI (a safe imaging scan) to detect and track dangerous changes in the mouth of people with Fanconi Anemia, a rare genetic condition. The goal is to find a better way to catch oral cancer early.
This study looks at how a breakdown product from alcohol (acetaldehyde) may play a role in oral (mouth) cancer. It may help researchers understand who is more affected by alcohol and why.
This Phase 2 study tests a stem cell transplant approach using adjusted chemotherapy doses for people with Fanconi anemia. It may help replace damaged bone marrow and treat blood problems like severe aplastic anemia, MDS, or leukemia.
Hear when a new Fanconi Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.